DUBLIN--(BUSINESS WIRE)--The "Inhalers - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.
The Medical Devices sector report provides an overview of Inhalers currently in pipeline stage. The report provides comprehensive information on pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalers pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
Scope
- Extensive coverage of the Inhalers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inhalers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Inhalers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Inhalers Overview
3 Products under Development
3.1 Inhalers - Pipeline Products by Stage of Development
3.2 Inhalers - Pipeline Products by Segment
3.3 Inhalers - Pipeline Products by Territory
3.4 Inhalers - Pipeline Products by Regulatory Path
3.5 Inhalers - Pipeline Products by Estimated Approval Date
3.6 Inhalers - Ongoing Clinical Trials
4 Inhalers - Pipeline Products under Development by Companies
4.1 Inhalers Companies - Pipeline Products by Stage of Development
4.2 Inhalers - Pipeline Products by Stage of Development
5 Inhalers Companies and Product Overview
6 Inhalers- Recent Developments
6.1 May 04, 2019: Vectura wins US GSK patent litigation and awarded $89.7Million in damages by trial jury
6.2 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury
6.3 May 03, 2019: Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019
6.4 May 02, 2019: Teva reports first quarter 2019 financial results
6.5 May 01, 2019: United Therapeutics reports first quarter 2019 financial results
6.6 May 01, 2019: GSK delivers sales of 7.7 billion +6% AER, +5% CER
6.7 Apr 30, 2019: Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact
6.8 Apr 30, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 March 2019
6.9 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
6.10 Apr 25, 2019: Orion Group Interim report January-March 2019
7 Appendix
Companies Mentioned
- Acorda Therapeutics Inc
- Adamis Pharmaceuticals Corp
- Advent Pharmaceuticals Pty Ltd
- Aespira Ltd.
- AKELA Pharma Inc.
- Alexza Pharmaceuticals Inc
- Aradigm Corp
- AstraZeneca Plc
- Bayer AG
- Bellerophon Therapeutics Inc
- Bespak Europe Ltd
- Boehringer Ingelheim GmbH
- Circassia Pharmaceuticals Plc
- Drexel University
- Eli Lilly and Co
- FocusStart LLC
- GlaxoSmithKline Plc
- Lupin Pharmaceuticals Inc
- MannKind Corp
- Medihale Ltd
- Monash University
- Nektar Therapeutics
- North Carolina State University
- Novartis AG
- Ology Bioservices Inc
- OPKO Health Inc
- OtiTopic LLC
- Perrigo Co Plc
- Pharmaxis Ltd
- Pneuma Respiratory Inc
- Resolve Digital Health Inc
- Respira Therapeutics Inc
- Sandoz International GmbH
- Seng Vital International GmbH
- Senzer Ltd
- Sheffield Hallam University
- Softhale NV
- Spyryx Biosciences Inc
- Sun Pharma Advanced Research Company Ltd
- Syqe Medical
- Tetra Bio-Pharma Inc
- Teva Pharmaceutical Industries Ltd
- United Therapeutics Corp
- University of Kansas
- University of Sydney
- University of Texas Medical Branch at Galveston
- Uscom Ltd.
- Vectura Group Plc
- Verona Pharma Plc
- Virginia Commonwealth University
For more information about this report visit https://www.researchandmarkets.com/r/ihrhgz
